Pharma Journalist -

Corvus Pharmaceuticals, Inc. announced that it has initiated a Phase 1 study to investigate a novel immunotherapy approach for patients with COVID-19. The first cohort of five patients…
Read More...

Turning Point Therapeutics, Inc. and Zai Lab announced an exclusive license agreement for the development and commercialization of Turning Point’s lead drug candidate, repotrectinib, in…
Read More...

The European Investment Bank (EIB) and CureVac, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on optimised mRNA, entered into a €75…
Read More...

Novavax, Inc. announced that it has been selected to participate in Operation Warp Speed (OWS), a U.S. government program that aims to begin delivering millions of doses of a safe,…
Read More...

GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s…
Read More...

Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, announced it has raised $110 million in a Series B financing.…
Read More...

Regeneron Pharmaceuticals, Inc. announced the initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron's investigational double antibody cocktail for the treatment and…
Read More...

Sunovion Pharmaceuticals Inc. (Sunovion) announced topline results from study SEP380-201, a global, multicenter, randomized, double-blind, placebo-controlled clinical trial designed to…
Read More...

SMi reports: SMi are pleased to inform you that Matthew Catley from MiNa Therapeutics Ltd has confirmed his position as speaker SMi are pleased to inform you that Matthew Catley,…
Read More...

Unum Therapeutics Inc. announced it has completed the acquisition of Kiq LLC, a privately held, biotechnology company focused on the discovery and development of precision kinase…
Read More...